SUN VALLEY, Calif., Feb. 14 /PRNewswire-FirstCall/ -- XTend Medical Corporation announced today the company has begun a remote diabetic monitoring program with a target of 500 patients to be part of the initial program.
The program, facilitated through local physicians in Southern California, will remotely monitor diabetic patients through the XTend Medical Disease Management Program. The patients will be able to take their glucose readings and transmit the results to the participating physicians via the Eocene transmitter. Once the glucose meter is cradled to Eocene unit, the plug-in system utilizes a standard phone line to send the encrypted patient data to a central server for review by the physician. Once the data is reviewed by the physician, then any adjustments in medication, compliance with testing, and/or any necessary follow-up visits can be relayed immediately to the patient.
“This remote diabetic monitoring program is nothing short of groundbreaking for the company and the medical community. Our system is designed for physicians to be able to closely monitor diabetic patients from their office while the patients maintain their regular daily lives in their own homes. The patient’s data can be securely monitored and any adjustments can be made instantaneously through direct communication with the patient from a remote location,” stated Mr. Paul D. Lisenby, CEO of XTend Medical. Mr. Lisenby further states, “XTend Medical is now poised to implement this system nationwide to any healthcare company looking to remotely monitor their diabetic patients. Our ability to implement the system very rapidly is now in place. Our revenue projections for 2008 should be attainable now that we’ve set this program in motion.”
For any healthcare agency of physician group that would like to find out how this program can be of benefit, please visit the company website at www.xtendmedical.com.
About XTend Medical:
XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients. For more information, please visit their website at www.xtendmedical.com.
Safe Harbor
This press release contains or may contain forward-looking statements such as statements regarding the Company’s growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.
Contact: FutureTechIR for XTend Medical Corporation
CONTACT: Investor Relations of FutureTechIR, +1-817-812-2105, for XTend
Medical Corporation
Web site: http://www.xtendmedical.com/
